Chatham Biotec, Limited
Records under this name other than patents Chatham Biotec, Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Chatham Biotec, Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,592,588 | Process to prepare camptothecin derivatives Lapsed on the fee record Ended Nov 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2025 | From the USPTO record |
| US 8,299,279 | Semi-synthetic process for the preparation of taxane derivatives Lapsed on the fee record Ended Oct 30, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2020 | From the USPTO record |
| US 8,293,930 | One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel Lapsed on the fee record Ended Oct 23, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 23, 2020 | From the USPTO record |
| US 7,906,661 | Semi-synthetic conversion of paclitaxel to docetaxel Lapsed on the fee record Ended Mar 15, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 15, 2019 | From the USPTO record |
| US 7,893,283 | Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel Lapsed on the fee record Ended Feb 22, 2019 · From the USPTO record | Lapsed on the fee record | Ended Feb 22, 2019 | From the USPTO record |
| US 7,838,694 | Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes Lapsed on the fee record Ended Nov 23, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 23, 2018 | From the USPTO record |
| US 6,222,053 | Semi-synthesis of a protected baccatin III compound Term ended Term ended Oct 17, 2017 · From the USPTO record | Term ended | Term ended Oct 17, 2017 | From the USPTO record |
| US 6,576,777 | Semi-synthesis of a protected baccatin III compound Term ended Term ended Oct 17, 2017 · From the USPTO record | Term ended | Term ended Oct 17, 2017 | From the USPTO record |
| US 7,585,986 | Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel Lapsed on the fee record Ended Sep 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2017 | From the USPTO record |